CROI (Conference on Retroviruses and Opportunistic Infections)

The Latest

Research Is Still Exploring Best Treatment Strategies for Pregnant and Breastfeeding Women, Interactions With Contraceptives

Several new studies presented at the annual Conference on Retroviruses and Opportunistic Infections (CROI) underscore the complex ways that HIV risk and treatment adherence manifest among women of childbearing age.

By Sony Salzman

HIV/HCV Coinfection: New Data Has Implications for Treatment-as-Prevention Efforts

Researchers at this year's Conference on Retroviruses and Opportunistic Infections (CROI) presented their findings on the ongoing challenges of treating hepatitis C infection among people with HIV.

By Sony Salzman

Rate of Bone Loss on ART Slows After the First Year

Reassuring data that the initial loss in bone mineral density during the first year of antiretroviral therapy slowed during subsequent years.

By Simon Collins for HIV i-Base

CROI 2018: Highlights and What's Next for Advocates

This year's Conference on Retroviruses and Opportunistic Infections broadened its lens from the lab to the ways that different strategies are, or might, have an impact in the context of people's complex lives.

By AVAC: Global Advocacy for HIV Prevention

Injection Drug Use Among People Living With HIV: A Missed Opportunity to Save Lives

Panelists at CROI 2018 painted a bleak picture of the scale of the country's addiction crisis, noting that the never-before-seen dynamics of the current drug epidemic require creative approaches to HIV treatment and prevention among people who inject...

By Sony Salzman

Statin Use Might Reduce Risk of Cancer in HIV-Positive People

A large case-control analysis reported an overall association between statin use and a reduced risk of virus-mediated cancers in HIV-positive people.

By Simon Collins for HIV i-Base

Reported PrEP 'Failure' Most Likely a Lack of Proper Testing and Adherence

When is a pre-exposure prophylaxis (PrEP) failure actually a provider failure? And how do we tell the difference?

By Damon L. Jacobs, L.M.F.T.

Really Rapid Review -- CROI 2018, Boston

“CROI clearly remains our best meeting,” writes Paul E. Sax, M.D., “the only one that brings together so much high quality research from so many disciplines.”

By Paul E. Sax, M.D. for NEJM Journal Watch

Dr. Gina Brown on Highlights of Research on Women and HIV From CROI 2018

Gina Brown, M.D., shares her reflections on some of the many research findings about HIV prevention, care, and treatment for women and girls presented at CROI 2018.

By HIV.gov

Insurers and Pharmas Must Help Fix HIV Drug Pricing System, Advocates Say

The Fair Pricing Coalition is working with pharmaceutical companies to ensure fair prices for new HIV drugs on par with those of older medications.

By Barbara Jungwirth